Pentax Medical, a unit of Hoya Group, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its IMAGINA endoscopy system.

The endoscopy platform was developed for gastrointestinal (GI) procedures at ambulatory surgery centres (ASC).

IMAGINA’s user interface and endoscope design features will provide practitioners with enhanced visualisation and improved operator experience.

Pentax Medical designed the system to meet ACS requirements and avoid the trade-off between cost and quality care.

IMAGINA system comprises a sleek and touch-screen LCD interface on the processor and offers images in 1080p resolution. It also helps to avoid the use of expensive periodic bulb replacements, providing better cost predictability.

The system also features Pentax i-SCAN real-time and digital image enhancement technology, which offers an improved view of the texture of the mucosal surface and the blood vessels to the user.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the IMAGINA i10c series is the only endoscope platform that offers distally mounted LED lights, HD+ CMOS image sensor and PENTAX i-SCAN, allowing clear visualisation to assess GI tract.

Pentax Medical Americas president and CEO David Woods said: The launch of the IMAGINA allows us to best serve the needs of the core GI market and our system provides maximum cost predictability without compromising on the standard of care delivered to patients.

“IMAGINA eliminates the costliest components of a premium GI endoscopy system and still adheres to the highest imaging standards in the industry: a true testament to our commitment to better patient outcomes, improved patient experience and a lower overall cost of care.”

In November, the FDA gave marketing approval for the Pentax Medical Video Duodenoscope ED34-i10T2, the first duodenoscope with a sterile, disposable elevator component.